Moderna Vaccine Doses
- All
- News
- Videos
-
Covid Vaccine Scheme For The Poorest Pushes For Delivery Slowdown: Report
Leaders of the global scheme aiming to get COVID-19 vaccines to the world's poorest are pushing manufacturers,including Pfizer and Moderna, to cut or slow deliveries of about half a billion shots so doses are not wasted.
-
Moderna Recalls Thousands Of Covid Doses In Europe. Here's Why
Moderna Inc said on Friday it was recalling 764,900 doses of its COVID-19 vaccine made by its contract manufacturer Rovi after a vial was found contaminated by a foreign body.
-
Oil Prices Plunge As Omicron's Rapid Spread Dims Fuel Demand Outlook
Oil prices fell despite Moderna Inc's announcement on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against Omicron in laboratory testing.
-
Covid Booster Efficacy Reduces Significantly By 4th Month: US Study
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
-
How Long Does A Covid Booster Shot Offer Protection? US Study Answers
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
-
Moderna Begins Omicron-Specific Vaccine Trials After Pfizer-BioNTech
US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.
-
Fourth Covid Vaccine "Partially" Effective Against Omicron: Study
Fourth doses of the Pfizer and Moderna vaccines against Covid-19 are only "partially" effective for the Omicron variant of the virus, the authors of an Israeli trial said Monday.
-
Moderna Says Third Dose Boosts Antibodies Against Omicron
A third dose of Moderna Inc.'s Covid-19 vaccine increased antibody levels against the omicron variant, results the company described as reassuring while it works on a shot tailored to the new strain.
-
6 Vaccines Show Promise As Boosters, Led By Pfizer And Moderna
A U.K. study testing seven different Covid-19 vaccines as booster doses found most of them increased antibodies, with shots from Moderna Inc. and the Pfizer Inc.-BioNTech SE partnership performing best.
-
UK Orders 114 Million Additional Covid Jabs Amid 'Omicron' Variant Scare
The UK government said late Wednesday it has ordered 114 million additional Covid-19 vaccine doses, from pharmaceutical giants Pfizer-BioNTech and Moderna, to bolster its jabs drive over the next two years.
-
Covid Vaccine Scheme For The Poorest Pushes For Delivery Slowdown: Report
Leaders of the global scheme aiming to get COVID-19 vaccines to the world's poorest are pushing manufacturers,including Pfizer and Moderna, to cut or slow deliveries of about half a billion shots so doses are not wasted.
-
Moderna Recalls Thousands Of Covid Doses In Europe. Here's Why
Moderna Inc said on Friday it was recalling 764,900 doses of its COVID-19 vaccine made by its contract manufacturer Rovi after a vial was found contaminated by a foreign body.
-
Oil Prices Plunge As Omicron's Rapid Spread Dims Fuel Demand Outlook
Oil prices fell despite Moderna Inc's announcement on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against Omicron in laboratory testing.
-
Covid Booster Efficacy Reduces Significantly By 4th Month: US Study
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
-
How Long Does A Covid Booster Shot Offer Protection? US Study Answers
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
-
Moderna Begins Omicron-Specific Vaccine Trials After Pfizer-BioNTech
US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.
-
Fourth Covid Vaccine "Partially" Effective Against Omicron: Study
Fourth doses of the Pfizer and Moderna vaccines against Covid-19 are only "partially" effective for the Omicron variant of the virus, the authors of an Israeli trial said Monday.
-
Moderna Says Third Dose Boosts Antibodies Against Omicron
A third dose of Moderna Inc.'s Covid-19 vaccine increased antibody levels against the omicron variant, results the company described as reassuring while it works on a shot tailored to the new strain.
-
6 Vaccines Show Promise As Boosters, Led By Pfizer And Moderna
A U.K. study testing seven different Covid-19 vaccines as booster doses found most of them increased antibodies, with shots from Moderna Inc. and the Pfizer Inc.-BioNTech SE partnership performing best.
-
UK Orders 114 Million Additional Covid Jabs Amid 'Omicron' Variant Scare
The UK government said late Wednesday it has ordered 114 million additional Covid-19 vaccine doses, from pharmaceutical giants Pfizer-BioNTech and Moderna, to bolster its jabs drive over the next two years.
